CSR push: NSE to invest Rs 380-cr for cancer facility at Tata Memorial Centre; India’s largest BMT centre to set up
India's largest equity bourse, NSE, will invest Rs 380 crore to build a new 11-storey multi-speciality cancer treatment block and India's largest bone marrow transplant centre at TMH-run ACTREC in Navi Mumbai. Expected by July 2027, this CSR-funded facility aims to handle 1.3 lakh outpatient visits annually and over 600 BMTs, significantly addressing critical healthcare gaps for cancer patients.
India's largest equity bourse, NSE, will invest Rs 380 crore to build a new 11-storey multi-speciality cancer treatment block and India's largest bone marrow transplant centre at TMH-run ACTREC in Navi Mumbai. Expected by July 2027, this CSR-funded facility aims to handle 1.3 lakh outpatient visits annually and over 600 BMTs, significantly addressing critical healthcare gaps for cancer patients.
